borderline significancep = 0.06
A shorter recurrence-to-death period (tumor-bearing survival (TBS)) was observed in Group III than in Group II with a borderline significance ( p = 0.06).
A shorter recurrence-to-death period (tumor-bearing survival (TBS)) was observed in Group III than in Group II with a borderline significance ( p = 0.06).